Geographic Inequities in Access to Phase 3 Clinical Trials for Inflammatory Bowel Disease in the United States. Boyd T, Ananthakrishnan AN. Clin Gastroenterol Hepatol 2024;22:659-661.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boyd T, Ananthakrishnan AN. Geographic Inequities in Access to Phase 3 Clinical Trials for Inflammatory Bowel Disease in the United States. Clin Gastroenterol Hepatol 2024;22:659-661.
PMID: 37572861